Introduction
Obstructive lung diseases, principally asthma and chronic obstructive pulmonary disease (COPD), represent two of the most common causes of acute hypercapnic respiratory failure requiring mechanical ventilation in both emergency and critical care settings. Although they share the physiological hallmark of airflow obstruction, their underlying mechanisms, pathological trajectories, and responses to ventilator management differ meaningfully. Delivering mechanical ventilation to these patients demands a thorough understanding of respiratory mechanics, gas exchange physiology, and the hazards introduced by the ventilator itself. Inappropriate ventilation strategies in this population remain a significant contributor to in-hospital morbidity and mortality. This paper reviews the current evidence base for ventilator management of patients with asthma and COPD in acute respiratory failure, with emphasis on key parameters, lung-protective principles, and emerging strategies relevant to both emergency and intensive care providers.
Pathophysiology of Obstruction and Dynamic Hyperinflation
The central physiological challenge in ventilating patients with obstructive disease is dynamic hyperinflation (DHI), also termed auto-PEEP or intrinsic PEEP. In both asthma and COPD, expiratory airflow is limited by airway narrowing, mediated through bronchospasm, mucosal edema, and increased secretions in asthma, and by loss of elastic recoil along with small airway destruction in COPD. When the respiratory rate or tidal volume is set too high, exhalation is incomplete before the next breath is initiated. Air traps progressively in the lungs, increasing end-expiratory lung volume, elevating mean airway pressures, and generating intrinsic positive end-expiratory pressure (iPEEP). The consequences are severe: barotrauma, hemodynamic compromise from impaired venous return, and an increased work of breathing for triggered breaths. Studies have demonstrated that DHI can result in peak airway pressures exceeding 50 cmH₂O and plateau pressures above safe thresholds in inadequately managed ventilated asthma patients (Leatherman, 2015). Recognition and mitigation of DHI is therefore the cornerstone of ventilator strategy in obstructive disease.
Ventilator Settings: Core Principles
Tidal Volume and Respiratory Rate
Current evidence supports the use of low tidal volumes in conjunction with slow respiratory rates as the primary strategy to limit DHI and prevent barotrauma. A tidal volume of 6–8 mL/kg of ideal body weight (IBW) is recommended, consistent with lung-protective principles derived from the ARDS literature and adapted for obstruction (Brenner et al., 2009; Oddo et al., 2006). Respiratory rate should be set conservatively at 10–14 breaths per minute in most ventilated asthma patients and 12–16 breaths per minute in COPD, though these should be titrated against the observed I:E ratio and evidence of air trapping. The goal is to allow adequate expiratory time: an I:E ratio of at least 1:3 to 1:4 is frequently recommended in severe obstruction, particularly in status asthmaticus (Leatherman, 2015).
Permissive Hypercapnia
A critical shift in ventilator philosophy for obstructive disease over the past two decades has been the acceptance of permissive hypercapnia (also termed controlled hypoventilation). Rather than aggressively normalizing PaCO₂ at the expense of dangerous airway pressures, clinicians allow CO₂ to rise, accepting a pH as low as 7.20–7.25, in exchange for lower plateau pressures and reduced air trapping. Evidence supports this strategy in mechanically ventilated asthmatics, where mortality has been shown to decrease when plateau pressures are kept below 30 cmH₂O (Leatherman, 2015; Brenner et al., 2009). In COPD, many patients have chronic hypercapnia at baseline, making permissive hypercapnia even more contextually appropriate, provided the pH remains tolerable and hemodynamics are stable. Bicarbonate infusion may be considered when acidosis is severe, though its routine use remains debated.
PEEP Strategy
The role of extrinsic PEEP (ePEEP) in obstructive disease is nuanced. Unlike in ARDS, where ePEEP is used to recruit collapsed alveoli, in obstructive disease the primary concern is avoiding the additive burden of ePEEP on already elevated iPEEP. In general, ePEEP should be kept at the lowest effective level, typically 0–5 cmH₂O, in most ventilated asthma patients with significant air trapping (Oddo et al., 2006). In COPD, the situation is more complex: low-level ePEEP (set to approximately 80% of measured iPEEP) may actually facilitate patient triggering by reducing the pressure threshold required to initiate a breath, thereby decreasing work of breathing in spontaneously breathing patients on assisted modes. This approach has been validated in multiple studies of COPD patients receiving pressure support or SIMV ventilation (Laghi & Goyal, 2012).
Mode Selection
Volume-controlled ventilation (VCV) with a constant flow waveform is traditionally favored in the acute management of severe asthma, as it allows direct monitoring of airway pressures and plateau pressures, providing early warning of worsening DHI. A decelerating flow pattern (available in pressure-controlled ventilation, or PCV) may offer advantages in terms of gas distribution in some patients, but the variable tidal volume delivery of PCV can be unpredictable in the setting of rapidly changing airway resistance. For COPD patients capable of triggering, pressure support ventilation (PSV) — titrated to achieve a tidal volume of 6–8 mL/kg IBW — reduces sedation requirements and improves patient-ventilator synchrony. Evidence from trials comparing PSV to VCV in COPD exacerbations suggests equivalent clinical outcomes with fewer days of ventilation in some cohorts (Brochard et al., 1995). Airway pressure release ventilation (APRV) has limited evidence in obstruction and is generally not recommended as a first-line mode in these populations (Hess, 2013).
Non-Invasive Ventilation and High-Flow Oxygen
Non-invasive positive pressure ventilation (NIV), encompassing both CPAP and BiPAP, has an established role in COPD exacerbations and is strongly recommended as first-line intervention in hypercapnic respiratory failure where the patient can protect their airway (Osadnik et al., 2017). A landmark meta-analysis demonstrated that NIV in COPD exacerbations reduces intubation rates, decreases in-hospital mortality, and shortens ICU and hospital length of stay (Ram et al., 2004). For asthma, the evidence for NIV is less robust, though several studies suggest benefit in carefully selected patients with mild-to-moderate severity (Soroksky et al., 2003). High-flow nasal cannula (HFNC) oxygen therapy has emerged as an alternative to NIV in COPD, particularly in patients who are intolerant of a mask interface; however, evidence remains less conclusive than for NIV, and HFNC should not be substituted for NIV in the presence of significant hypercapnia (Pisani et al., 2017).
Monitoring and Titration
Accurate monitoring is essential to safe ventilator management in obstruction. Plateau pressure should be measured routinely via an inspiratory hold maneuver and maintained below 30 cmH₂O. Intrinsic PEEP is quantified through an expiratory hold and should be measured serially. Waveform capnography provides continuous, non-invasive insight into the adequacy of ventilation and the presence of obstructive physiology (the characteristic "shark-fin" or sloped capnogram plateau). Arterial blood gas analysis remains the gold standard for assessing pH, PaCO₂, and oxygenation, guiding permissive hypercapnia strategies. In patients with asthma, short-term paralysis with neuromuscular blockade may be required in the first 24–48 hours of ventilation to facilitate adequate gas exchange, eliminate patient-ventilator dyssynchrony, and allow DHI to resolve, though prolonged paralysis is associated with critical illness myopathy and should be minimized (Leatherman, 2015).
In Summary
Mechanical ventilation in asthma and COPD demands a strategy fundamentally different from that used in parenchymal lung disease. The guiding principles — permissive hypercapnia, low tidal volumes, low respiratory rates to allow adequate exhalation, and careful PEEP titration — reflect a physiologically informed approach designed to minimize dynamic hyperinflation while maintaining hemodynamic stability. Non-invasive ventilation remains the preferred initial strategy in COPD exacerbations with established mortality benefit. As monitoring capabilities and ventilator technology evolve, the management of these patients continues to be refined, but the core tenet of respecting the obstructed lung and prioritizing safety over the normalization of blood gas values remains unchanged.
References
- Brenner, B., Corbridge, T., & Kazzi, A. (2009). Intubation and mechanical ventilation of the asthmatic patient in respiratory failure. Journal of Emergency Medicine, 37(2 Suppl), S23–S34.
https://doi.org/10.1016/j.jemermed.2009.06.108
- Brochard, L., Mancebo, J., Wysocki, M., Lofaso, F., Conti, G., Rauss, A., ... & Lemaire, F. (1995). Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. New England Journal of Medicine, 333(13), 817–822.
https://doi.org/10.1056/NEJM199509283331301
- Hess, D. R. (2013). Ventilator waveforms and the physiology of pressure support ventilation. Respiratory Care, 50(2), 166–186.
- Laghi, F., & Goyal, A. (2012). Auto-PEEP in respiratory failure. Minerva Anestesiologica, 78(2), 201–221.
- Leatherman, J. (2015). Mechanical ventilation for severe asthma. Chest, 147(6), 1671–1680.
https://doi.org/10.1378/chest.14-1684
- Oddo, M., Feihl, F., Schaller, M. D., & Perret, C. (2006). Management of mechanical ventilation in acute severe asthma: Practical aspects. Intensive Care Medicine, 32(4), 501–510.
https://doi.org/10.1007/s00134-005-0045-x
- Osadnik, C. R., Tee, V. S., Carson-Chahhoud, K. V., Picot, J., Wedzicha, J. A., & Smith, B. J. (2017). Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews, 7, CD004104.
https://doi.org/10.1002/14651858.CD004104.pub4
- Pisani, L., Fasano, L., Corcione, N., Comellini, V., Musti, M. A., Brandao, M., ... & Nava, S. (2017). Change in pulmonary mechanics and the effect on breathing pattern of high flow oxygen therapy in stable hypercapnic COPD. Thorax, 72(4), 373–375.
https://doi.org/10.1136/thoraxjnl-2016-209673
- Ram, F. S., Picot, J., Lightowler, J., & Wedzicha, J. A. (2004). Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews, 3, CD004104.
https://doi.org/10.1002/14651858.CD004104.pub2
- Soroksky, A., Stav, D., & Shpirer, I. (2003). A pilot prospective, randomized, placebo-controlled trial of bilevel positive airway pressure in acute asthmatic attack. Chest, 123(4), 1018–1025.
https://doi.org/10.1378/chest.123.4.1018